As of 2025-10-26, the EV/EBITDA ratio of Medipharm Labs Corp (LABS.TO) is -3.78. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LABS.TO's latest enterprise value is 31.56 mil CAD. LABS.TO's TTM EBITDA according to its financial statements is -8.34 mil CAD. Dividing these 2 quantities gives us the above LABS.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.9x - 14.6x | 13.4x |
| Forward P/E multiples | 4.6x - 16.5x | 5.4x |
| Fair Price | (0.22) - (0.29) | (0.19) |
| Upside | -387.5% - -486.9% | -348.4% |
| Date | EV/EBITDA |